<html>
<head>PUBMED IDs for CMG-2</head>
<body bgcolor='#C5F0F2'><h1>CMG-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11683410/'>Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.</a> October 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12973667/'>Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.</a> September 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15365459/'>Infantile Systemic Hyalinosis: report of three unrelated Brazilian children and review of the literature.</a> September 15  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16238086/'>A solitary calvarial lytic lesion with typical histopathological findings of juvenile hyaline fibromatosis.</a> October 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/21196249/'>Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.</a> April 22  2011<br></body></html>
